ACADIA PHARMACEUTICALS INC Logo

ACADIA PHARMACEUTICALS INC

Biopharmaceutical company developing medicines for CNS disorders and rare diseases.

ACAD | US

Overview

Corporate Details

ISIN(s):
US0042251084
LEI:
Country:
United States of America
Address:
12830 EL CAMINO REAL, 92130 SAN DIEGO

Description

ACADIA PHARMACEUTICALS INC. is a biopharmaceutical company focused on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases. The company's commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. Acadia is advancing a diverse clinical pipeline with mid- to late-stage programs targeting conditions such as Alzheimer's disease psychosis and Lewy body dementia psychosis, alongside early-stage programs addressing other unmet patient needs. The company's mission is to provide innovative therapies and support to underserved patient communities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-19 19:00 English ZIP 8.5 KB
2025-11-19 19:00 English ZIP 8.4 KB
2025-11-14 09:16 English ZIP 9.9 KB
2025-11-12 19:00 English ZIP 7.2 KB
2025-11-10 18:59 English ZIP 7.2 KB
2025-11-05 19:47
10-Q
English ZIP 1.6 MB
2025-11-05 17:13
8-K
English ZIP 95.2 KB
2025-11-03 17:23
8-K
English ZIP 51.0 KB
2025-09-16 20:00 English ZIP 7.3 KB
2025-09-03 20:00 English ZIP 7.0 KB
2025-08-19 20:00 English ZIP 7.2 KB
2025-08-18 18:31 English ZIP 6.9 KB
2025-08-06 19:53
10-Q
English ZIP 2.7 MB
2025-08-06 18:18
8-K
English ZIP 96.3 KB
2025-06-10 18:06
8-K
English ZIP 53.4 KB

Automate Your Workflow. Get a real-time feed of all ACADIA PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ACADIA PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ACADIA PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AMARIN CORP PLC\UK Logo
Develops and commercializes therapeutics to improve cardiovascular health.
United States of America
AMRN
AMGEN INC Logo
A biotechnology company developing human therapeutics for serious illnesses.
United States of America
AMGN
Industrial biotechnology company specializing in specialty enzymes and proteins.
South Korea
092040
AMICUS THERAPEUTICS, INC. Logo
Biotechnology company developing therapies for rare genetic and devastating diseases.
United States of America
FOLD
AMINOLOGICS CO.,LTD. Logo
Specialty manufacturer of high-purity chiral amino acids and their derivatives.
South Korea
074430
Amneal Pharmaceuticals, Inc. Logo
Develops, manufactures, and distributes generic and specialty pharmaceuticals.
United States of America
AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops, manufactures, and markets technically challenging medications.
United States of America
AMPH
Amylyx Pharmaceuticals, Inc. Logo
Develops therapies for neurodegenerative diseases and other unmet medical needs.
United States of America
AMLX
AN2 Therapeutics, Inc. Logo
Biopharmaceutical firm developing boron-based drugs for infectious diseases.
United States of America
ANTX
Biopharmaceutical firm developing cannabinoid-based medicines for inflammatory conditions.
United Kingdom
ANAN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.